Navigation Links
Catabasis Pharmaceuticals Announces Issuance of Patents for CAT-1000 and CAT-2000 Series
Date:4/30/2013

CAMBRIDGE, Mass., April 30, 2013 /PRNewswire/ -- Catabasis Pharmaceuticals Inc., announced that the United States Patent and Trademark Office has issued patents that cover CAT-1000 and CAT-2000 series compounds. One patent (U.S. Patent No. 8,173,831) covers the CAT-1000 series' conjugation of salicylate and an omega-3 fatty acid using Catabasis' SMART Linker technology; the compounds in this series are intended to treat diseases involving chronic inflammation such as inflammatory bowel disease and Duchenne muscular dystrophy. CAT-2000 series' patents (U.S. Patent Nos. 8,304,551 and 8,304,552) cover SMART Linker conjugation of niacin and an omega-3 fatty acid. CAT-2003, the series' lead compound, is being tested for patients with severe hypertriglyceridemia. The patents cover composition of matter for both series, including lead products CAT-1004 and CAT-2003, until 2029 and 2030 respectively.

"These patents, along with others in our portfolio, provide multi-layered protection for our SMART Linker conjugates in the CAT-1000 and CAT-2000 series," said Jill Milne , Ph.D., chief executive officer of Catabasis. "The patents validate our unique chemistry platform. We create new compounds, conjugated using our SMART Linker technology, giving us the ability to
'/>"/>

SOURCE Catabasis Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Catabasis Initiates Phase 1 Trial of CAT-2003 for Treatment of Severe Hypertriglyceridemia
2. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
3. Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013
4. Auxilium Pharmaceuticals Completes Acquisition Of Actient Holdings LLC To Create A Leading Urology Franchise With A Diversified Product Portfolio And Strong Growth Profile
5. Absorption Pharmaceuticals to Receive Patent for Premature Ejaculation Topical Medication
6. Novartis Pharmaceuticals Corporation disputes allegations in two US Government lawsuits and looks forward to a fair discussion of the facts
7. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, May 2
8. Avanir Pharmaceuticals Receives Positive CHMP Opinion for Approval of NUEDEXTA in Europe
9. Cumberland Pharmaceuticals To Announce First Quarter 2013 Financial Results On May 2, 2013
10. Horizon Technology Finance Closes $2 Million Venture Loan Facility with New Haven Pharmaceuticals
11. Auxilium Pharmaceuticals to Announce First Quarter 2013 Results and Conduct Conference Call on Monday, April 29, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... , November 18, 2014 Investor-Edge ... EXEL ), Geron Corporation (NASDAQ: GERN ... Biopharma Inc. (NASDAQ: GALE ), and XOMA Corporation ... companies can be accessed at: http://investor-edge.com/register . ... a mixed note as the Dow Jones Industrial Average finished ...
(Date:11/18/2014)... Nov. 18, 2014 Pressure BioSciences, Inc. ... the installation of its first two Barozyme HT-48 ... potential sale. One system was placed in the ... Georgetown University while the other was placed in ... both settings, the Company believes the new systems ...
(Date:11/18/2014)... , November 18, 2014 ... knowledge of the overall new requirements of application dossiers ... China but also provides the guidance of ... for your products entry into the Chinese medical device ... medical device market is one of segment market of ...
Breaking Medicine Technology:Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 2Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 3Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 4Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 5Pressure BioSciences Ships First Two Barozyme HT48 Systems 2Pressure BioSciences Ships First Two Barozyme HT48 Systems 3Pressure BioSciences Ships First Two Barozyme HT48 Systems 4Pressure BioSciences Ships First Two Barozyme HT48 Systems 5Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 2Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 3Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 4Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 5Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 6Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 7Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 8
... Ariz.--(BUSINESS WIRE)--Jun 27, 2007 - Annals of,Internal Medicine ... on the impact of genistein on bone loss. ... Metabolism in Osteopenic,Postmenopausal Women-A Randomized Trial," appears in ... safety and efficacy of,genistein for the dietary management ...
... & CEO of the Lupus,Foundation of America, Inc., ... of America, Inc. and more than 1.5 million ... of the Phase,III clinical trials for CellCept(R), a ... Aspreva Pharmaceutical,Company. Development of new treatments for lupus ...
Cached Medicine Technology:New Proof of Genistein's Efficacy and Safety for Osteopenia and,Osteoporosis Published in Annals of Internal Medicine 2New Proof of Genistein's Efficacy and Safety for Osteopenia and,Osteoporosis Published in Annals of Internal Medicine 3Lupus Foundation of America Statement on Results for Clinical Study,of CellCept Released by Aspreva Pharmaceutical Company 2
(Date:11/18/2014)... Steven Reinberg ... News) -- People with the abnormal heartbeat known as ... their risk for bleeding and blood clots, according to ... among patients who took a blood thinner along with ... include aspirin, ibuprofen (Motrin), naproxen (Aleve) and celecoxib (Celebrex). ...
(Date:11/18/2014)... 17, 2014 (HealthDay News) -- Women who started smoking ... for chronic, severe menstrual pain, a new study suggests. ... pain. While smoking has been suspected as a risk ... inconclusive, the authors of the new study said. ... in a long-term study of women,s health in Australia. ...
(Date:11/18/2014)... OpenWorks, one of America’s leading commercial cleaning franchises, ... Invitational. The John C. Lincoln Health Foundation holds the ... Mission community programs. Open Works was a Tee Sponsor ... at Camelback Golf Club in Scottsdale. More than 250 ... Mission — including a food bank, children's dental clinic, ...
(Date:11/18/2014)... 2014 Sorrel Sky Gallery welcomes ... special selection of her beautiful, one-of-a-kind pieces. Just in time ... to the gallery, Friday, December 5 from 5 – 7:30 ... , Showers artistic creations began at her grandmother’s kitchen table ... inspire her designs. She studied at the Gemological Institute of ...
(Date:11/18/2014)... (HealthDay News) -- Hispanic women who,ve had at least five ... of heart trouble than those who,ve had fewer children or ... led by Shivani Aggarwal of Wake Forest School of Medicine ... Chicago, Miami, New York City and San Diego. About 12 ... children. A type of heart trouble called ventricular diastolic ...
Breaking Medicine News(10 mins):Health News:Some Painkillers Tied to Bleeding Risk in Those With Abnormal Heartbeat 2Health News:Study Ties Teen Smoking to Risk of Severe Menstrual Cramps 2Health News:OpenWorks Sponsors 2014 Lincoln Guild Invitational Golf Tournament Hosted by Scottsdale's Camelback Golf Club 2Health News:Elizabeth Showers Trunk Show & Personal Appearance Hosted by Sorrel Sky Gallery 2Health News:Certain Heart Dysfunction More Likely in Hispanic Women With Many Kids: Study 2
... , , SUNNYVALE, ... a global leader in the field of radiosurgery today announced that ... Robotic Radiosurgery System at Hopital Notre-Dame du CHUM, in Montreal, Canada. ... the CHUM,s Radio-oncology Department is a definite asset for our treatment ...
... , MOUNTAIN VIEW, Calif., Sept. 16 Recognized for ... Graham, will provide insight on health care reform at the Silicon ... a.m. at the Rotary Summit Center. , , With ... health care reform debate. El Camino Hospital, a non-profit community hospital that ...
... PARK, N.C., Sept. 16 GlaxoSmithKline (NYSE: GSK ) ... for patients who are unemployed, uninsured or struggling to make ends ... its patient assistance program, Bridges to Access, by offering two ways ... by telephone with the help of a healthcare advocate such as ...
... , WASHINGTON, Sept. 16 The U.S. ... to include a boxed warning regarding the injectable form of the ... will highlight the risk of serious tissue injury when this drug ... to the new boxed warning for this product, which is used ...
... , , FALLS CHURCH, ... recognized and innovative leader in digital pathology solutions, has been ... as the vendor to implement its digital pathology informatics vision. ... (Picture Archive and Communication System) solution to meet their operational ...
... , , , SEBASTOPOL, ... and exotic ingredients grows, rainforest-grown yerba mate is ... hit the market. , , (Photo: ... , a pioneer and leader in the yerba mate beverage category, ...
Cached Medicine News:Health News:First CyberKnife System Installed in Canada 2Health News:First CyberKnife System Installed in Canada 3Health News:First CyberKnife System Installed in Canada 4Health News:El Camino Hospital Provides Local Perspective on Health Care Reform and Innovation at Silicon Valley Healthcare CEO Summit 2Health News:GSK Makes it Easier for Unemployed, Uninsured to Get Free Medicines 2Health News:GSK Makes it Easier for Unemployed, Uninsured to Get Free Medicines 3Health News:FDA Requires Boxed Warning for Promethazine Hydrochloride Injection 2Health News:Apollo PACS, Inc. Selected by Henry Ford Health System for Its Digital Pathology Solution 2Health News:Apollo PACS, Inc. Selected by Henry Ford Health System for Its Digital Pathology Solution 3Health News:Guayaki Delivers Powerful Rainforest Experience with Newest Yerba Mate Beverage Innovations 2Health News:Guayaki Delivers Powerful Rainforest Experience with Newest Yerba Mate Beverage Innovations 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: